ArticleChiropractic & manual therapies2025
The role of preexisting analgesic use and self-efficacy for continued use of analgesics among patients with persistent low back pain.
Article in Chiropractic & manual therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Practical guide to structuring the Discussion section in clinical and epidemiological studies.Chiropractic & manual therapies · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVarious analgesics are frequently prescribed by physicians and used by patients with low back pain (LBP) despite limited effect on pain and disability and risk of side effects. Current knowledge on how psychological measures and self-management interventions influence analgesic use is limited. We investigated if analgesic use changed after participating in a patient education and exercise therapy program (GLA:D® Back), to what extent analgesic use and self-efficacy at baseline were potential determinants of analgesic use at the end of the program, and, to what extent improvement in self-efficacy from before to after the intervention modified the relationship between analgesic use at baseline and follow-up.
methodsWe used data from the Danish GLA:D
resultsAmong 4721 included participants, 34% of those using analgesics at baseline (n = 942) discontinued this at 3 months follow-up. Analgesic use at baseline was associated with increased odds of analgesic use at follow-up (odds ratio [OR]: 9.79, 95% confidence interval [CI]: 7.88, 12.15), and higher levels of self-efficacy at baseline was associated with decreased odds of analgesic use at follow-up (OR: 0.85, 95% CI: 0.81, 0.89). Improved self-efficacy, obtained during the program, reduced the risk of analgesic use at follow-up from 15 to 6% and from 76 to 54% among participants with and without baseline analgesic use respectively.
conclusionsPatients using analgesics when initiating care were more likely to use analgesics three months later, while those having high levels of self-efficacy were less likely. Improved self-efficacy during the program reduced the absolute risk of analgesic use following the intervention to a larger extent among those using analgesics at baseline compared to those without baseline use. Further investigation is needed to confirm whether these findings reflect causal effects.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.